As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
A new National Academies of Sciences, Engineering, and Medicine report provides an overview of new approach methods in human health risk assessment of chemicals, and calls on the U.S. Environmental ...